Contemporary outcomes following coronary artery bypass graft surgery for left main disease by Modolo, R, Chichareon, P, Kogame, N, Dressler, O, Crowley, A, Ben-Yehuda, O, Puskas, J, Banning, A, Taggart, D, Kappetein, A, Sabik, J, Onuma, Y, Stone, G, Serruys, P

Prognostic value of site SYNTAX score and rationale for combining anatomic and clinical factors in decision making: insights from the SYNTAX trial. by Zhang, Y, Iqbal, J, Campos, C, Klaveren, D, Bourantas, C, Dawkins, K, Banning, A, Escaned, J, de Vries, T, Morel, M, Farooq, V, Onuma, Y, Garcia-Garcia, H, Stone, G, Steyerberg, E, Mohr, F, Serruys, P

Final results of the HEALING IIB trial to evaluate a bio-engineered CD34 antibody coated stent (Genous™Stent) designed to promote vascular healing by capture of circulating endothe... by den Dekker, W, Houtgraaf, J, Onuma, Y, Benit, E, de Winter, R, Wijns, W, Grisold, M, Verheye, S, Silber, S, Teiger, E, Rowland, S, Ligtenberg, E, Hill, J, Wiemer, M, den Heijer, P, Rensing, B, Channon, K, Serruys, P, Duckers, H

Final results of the HEALING IIB trial to evaluate a bio-engineered CD34 antibody coated stent (Genous™Stent) designed to promote vascular healing by capture of circulating endothe... by den Dekker, W, Houtgraaf, J, Onuma, Y, Benit, E, de Winter, R, Wijns, W, Grisold, M, Verheye, S, Silber, S, Teiger, E, Rowland, S, Ligtenberg, E, Hill, J, Wiemer, M, den Heijer, P, Rensing, B, Channon, K, Serruys, P, Duckers, H

Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study by Banning, AP, Serruys, P, De Maria, GL, Ryan, N, Walsh, S, Gonzalo, N, Jan van Geuns, R, Onuma, Y, Sabate, M, Davies, J, Lesiak, M, Moreno, R, Cruz-Gonzalez, I, Hoole, SP, Piek, JJ, Appleby, C, Fath-Ordoubadi, F, Zaman, A, Van Mieghem, NM, Uren, N, Zueco, J, Buszman, P, Iniguez, A, Goicolea, J, Hildick-Smith, D, Ochala, A, Dudek, D, de Vries, T, Taggart, D, Farooq, V, Spitzer, E, Tijssen, J, Escaned, J

Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study. by Escaned, J, Collet, C, Ryan, N, De Maria, G, Walsh, S, Sabate, M, Davies, J, Lesiak, M, Moreno, R, Cruz-Gonzalez, I, Hoole, S, Ej West, N, Piek, J, Zaman, A, Fath-Ordoubadi, F, Stables, R, Appleby, C, van Mieghem, N, van Geuns, R, Uren, N, Zueco, J, Buszman, P, Iñiguez, A, Goicolea, J, Hildick-Smith, D, Ochala, A, Dudek, D, Hanratty, C, Cavalcante, R, Kappetein, A, Taggart, D, van Es, G, Morel, M, de Vries, T, Onuma, Y, Farooq, V, Serruys, P, Banning, A